Stock Alert: Fulgent Up 12% On Getting EUA For Its Covid-19 Testing

Shares of Fulgent Genetics, Inc. (FLGT) are surging more than 12% Monday morning after the company announced that Fulgent Therapeutics, LLC, a unit of Fulgent Genetics received Emergency Use Authorization (EUA) from the FDA for its RT-PCR test for the detection of SARS-CoV-2 virus that causes Covid-19.

Fulgent stock is currently trading at $18.57, close to its 52 week high of 20.60.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT